Lluis A Lopez-Barcons

Summary

Publications

  1. doi request reprint Serially heterotransplanted human prostate tumours as an experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    J Cell Mol Med 14:1385-95. 2010
  2. pmc Human benign prostatic hyperplasia heterotransplants as an experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, 70112, USA
    Asian J Androl 12:157-63. 2010
  3. pmc Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    Asian J Androl 12:308-14. 2010
  4. pmc Human prostate cancer heterotransplants: a review on this experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    Asian J Androl 12:509-18. 2010
  5. pmc Pegylated arginase I: a potential therapeutic approach in T-ALL
    Claudia P Hernandez
    Tumor Immunology Program, Stanley S Scott Cancer Center, Louisiana State University Health Sciences Center LSU HSC, New Orleans, LA 70112, USA
    Blood 115:5214-21. 2010

Collaborators

Detail Information

Publications5

  1. doi request reprint Serially heterotransplanted human prostate tumours as an experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    J Cell Mol Med 14:1385-95. 2010
    ....
  2. pmc Human benign prostatic hyperplasia heterotransplants as an experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, 70112, USA
    Asian J Androl 12:157-63. 2010
    ..Furthermore, heterotransplanted tissue preserves the three-dimensional tissular architecture of the prostate to maintain critical stromal-epithelial cell interactions...
  3. pmc Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    Asian J Androl 12:308-14. 2010
    ..Furthermore, heterotransplanted tissue preserves the three-dimensional tumor architecture of the prostate to maintain critical stromal-epithelial cell interactions...
  4. pmc Human prostate cancer heterotransplants: a review on this experimental model
    Lluis A Lopez-Barcons
    Stanley S Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA 70112, USA
    Asian J Androl 12:509-18. 2010
    ..Human PCa heterotransplants have considerable experimental advantages over cell culture following xenotransplantation...
  5. pmc Pegylated arginase I: a potential therapeutic approach in T-ALL
    Claudia P Hernandez
    Tumor Immunology Program, Stanley S Scott Cancer Center, Louisiana State University Health Sciences Center LSU HSC, New Orleans, LA 70112, USA
    Blood 115:5214-21. 2010
    ..The results suggest the potential benefit of L-Arginine depletion by peg-Arg I in the treatment of T-cell malignancies...